December 16, 2020
A new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effectiveway to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University’s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
E-Mail
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
Journal of Acquired Immune Deficiency Syndrome. In the first demonstration project among women who inject drugs, known as Project Sexual Health Equity (Project SHE), the team prescribed up to 24 weeks of daily PrEP, to 95 adult cisgender women those whose gender identity matches their sex assigned at birth. The study was based at the largest syringe services program in the mid-Atlantic Prevention Point Philadelphia located in the K